Evidence map›Paper›PMID 41844670›Full record

ArticleNPJ systems biology and applications2026

Context-aware synthetic promoter design using neural networks enables rewiring of eukaryotic transcriptional networks.

Lukas Kuhajda, Tomas Honzik, Jan Svec, Daniel Georgiev

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lukas KuhajdaNew Technologies for the Information Society, University of West Bohemia in Pilsen, Pilsen, Czechia.
Tomas HonzikNew Technologies for the Information Society, University of West Bohemia in Pilsen, Pilsen, Czechia.
Jan SvecDepartment of Cybernetics, University of West Bohemia in Pilsen, Pilsen, Czechia.
Daniel GeorgievDepartment of Cybernetics, University of West Bohemia in Pilsen, Pilsen, Czechia. georgiev@kky.zcu.cz.

Funding

MEYS CR LM2023055Ministry of Education, Youth and Sports of the Czech Republic 90254
6 · The paper itself

Abstract

Gene regulation through promoter engineering is a cornerstone of synthetic biology, enabling precise control over transcriptional networks. However, experimental approaches remain labor-intensive. While artificial neural networks (ANNs) have improved regulatory element prediction, tools for promoter-transcription factor binding site (TFBS) recombination are still lacking. We present an ANN framework for context-aware design of synthetic promoters in Saccharomyces cerevisiae. The model predicts optimal TFBS insertion sites and the extent of promoter rewriting needed for successful integration. Applying this, we screened 6,011 native yeast promoters for compatibility with the TetR TFBS, generating a ranked list of high-confidence promoter-TFBS pairs. Experimental validation showed that model-designed promoters achieved repression rates up to 98.4%, without prior experimental characterization or tuning. We further rewired the yeast transcriptional network by introducing glucose-dependent regulation of an essential gene via Mig1 TFBS insertion. These results establish a scalable, predictive method for engineering regulatory sequences and reprogramming transcriptional logic.

Indexed as

Gene Regulatory NetworksNeural Networks, ComputerPromoter Regions, GeneticBinding SitesGene Expression Regulation, FungalGenetic EngineeringRepressor ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSynthetic BiologyTranscription FactorsMIG1 protein, S cerevisiaeRepressor ProteinsSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID41844670
PMCPMC13144678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.